« Previous | Next » | All Messages |  MGEN Message Board Home | recommend post |  Ignore Poster

MGEN News Med Gen's Snorenz a Hit in New Zealand

BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (OTCBB:MGEN), manufacturers of nationally branded OTC healthier life products, announced that it has now shipped 8,000 bottles of its Snorenz® snore relief throat spray to Douglas Pharmaceuticals Ltd., its exclusive New Zealand distributor. This represents its fifth re-order. “The success of our international marketing push hinges on a constant flow of successes," said Mr. Paul Mitchell, President of Med Gen. He added, “We have gone all out to push our international business and have recently opened Ireland, Portugal, Australia and Spain."

On a domestic note, Mr. Kravitz, Chairman & CEO announced that more TV advertising has been booked for the UNDIET® System. These commercials will air the week of November 27, 2006 on AMC, Beauty & Fashion, Bet Jazz, Dish Women, Hits Female, Lime and CW+. The commercials have a new twist and offer a free trial of the entire UNDIET® System.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray’s the Way (“STW”). It is best known for producing the world’s first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the Un-Diet™ system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names.

Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol “MGEN”. For information contact Investor Relations 561-750-1100 or www.medgen.com.

This Press Release contains or incorporates by reference “forward looking statements" including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.